This finding suggested that EGFR mutations present in these specimens with TCC from 1 to 20% could be fairly identified by real-time PCR or NGS, providing therapeutic opportunities using EGFR-TKIs for these patients. Here, EGFR is linked to tarsal-carpal coalition syndrome.